dexamethasone
FDA Approves GSK’s Blenrep for Multiple Myeloma Treatment, Marking a Market Return
Blenrep; GSK; FDA Approval; Multiple Myeloma; Bortezomib; Dexamethasone
UK approval brings GSK’s Blenrep back from the brink
UK, Approved, Multiple Myeloma, DREAMM-8, dexamethasone, Blenrep, Antibody-Drug Conjugates, Risk, Cessation of life